Neoadjuvant Therapy for Resectable Pancreatic Cancer

Pancreas cancer is the fourth leading cause of cancer death, but estimated to become in the top three within a few years. Results are disappointing at best, but researchers are investigating better methods for treating this troublesome cancer in clinical trials. This is a post in ASCO Connection that explores how we can do better through timing therapies before surgery.

#pancreascancer #cancer

(701) 234-2251

©2018 by Sabha Ganai, MD, PhD, MPH, FACS